Interesting. That's a lot of time and money if you didn't think you would get approval. Also interesting on the pricing. Do you think those the sums Advent gets or NWBO gets?
Why is Advent the direct customer interface, and not NWBO? Who's getting the money? Looks like Advent is, and not those of us who invested in NWBO. Am I wrong?
Thank you! Looks like Northwest Biotherapeutics is reopening the UK Specials Program. (March 28?)
Dear XXXXX,
I am responding on behalf Carol Powers who will be unavailable for a few days. You contacted us November 6, 2020 regarding our dendritic cell vaccine being used to treat your brother's brain cancer.
At that time we were not accepting patients for our compassionate use / private pay for manufacture basis program. We appreciate your patience, especially since we know for anyone facing GBM, time is of the essence.
I hope you have been doing well and are staying safe and healthy. We are beginning to open the UK Specials Program to new patients and I wanted to give you more information about the vaccine and the manufacturing process to help you decide if you want to move forward.